Acanthamoeba Keratitis (AK) Market Insights and Epidemiology Forecast

1. Acanthamoeba Keratitis (AK) Market Growth Opportunities, Clinical Developmental Activities, Emerging Therapies, and Epidemiology Forecast in the 7MM Acanthamoeba Keratitis (AK) is a rare but serious eye infection that can result in permanent visual impairment or blindness. This infection is caused by a microscopic, free-living amoeba called Acanthamoeba. Two of the eight known species of Acanthamoeba, A. castellanii and A polyphaga, are responsible for most infections. The organism infects the transparent outer covering of the eye called the cornea. The protozoan is ubiquitous in nature and can be found in water bodies (for example, lakes and oceans), soil, air, cooling towers, heating, ventilating, air conditioning (HVAC) systems, and sewage systems. The condition is commonly misidentified as one of the more common fungal or viral forms of keratitis, especially ocular herpes, often delaying diagnosis. Corneal trauma, ocular surgery, contact lens use, and low levels of antiacanthamoeba IgA in tears are all risk factors for the development of AK. When the epithelial layer of the cornea is damaged, it is left susceptible to infection by fungi, bacteria, or protozoa. Before the widespread use of contact lenses, corneal abrasions and exposure to contaminated water or soil were the most distinguishable risk factors for AK. DelveInsight’s “Acanthamoeba Keratitis (AK) Market Insights, Epidemiology, and Market Forecast-2032″ report offer an in-depth understanding of the Acanthamoeba Keratitis (AK), historical and forecasted epidemiology as well as the Acanthamoeba Keratitis (AK) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some of the key facts of the Acanthamoeba Keratitis (AK) Market Report: ● According to the US Centers for Disease Control and Prevention (CDC), the majority of those who are affected by AK wear contact lenses An estimated 85% of cases in the US involve people who wear contact lenses According to Lacerda & Lira (2020) study, sight-threatening AK is most commonly found in young soft contact lens (CL) wearers and agricultural workers, though it can also be present in non-CL wearers Miltefosine (Impavido), an orphan-designated drug, is used off-label to treat AK. No drug therapy is approved for the indication, and the pipeline is also very narrow. According to Randag et al., (2019) study, although AK is a relatively uncommon disease, the incidence in soft contact lens wearers has increased to reach 1 in 21,000 in 2015 Gender-based Epidemiology of Acanthamoeba Keratitis estimates that the disease affects male and females equally ● ● ● ● ● Request a sample for the Acanthamoeba Keratitis (AK) Market Report Acanthamoeba Keratitis (AK) Symptoms The symptoms of Acanthamoeba Keratitis include – ● ● ● ● ● Pain in the eye Redness in the eye Blurred vision Sensitivity to light A sensation of something in the eye

2. Epidemiology Segmentation of Acanthamoeba Keratitis (AK): ● ● ● ● Prevalent Cases of Acanthamoeba Keratitis (AK) in the 7MM [2019-2032] Age-Specific Cases of Acanthamoeba Keratitis (AK) in the 7MM [2019–2032] Gender-Specific Cases of Acanthamoeba Keratitis (AK) in the 7MM [2019–2032] Diagnosed and Treated Cases of Acanthamoeba Keratitis (AK) in the 7MM [2019–2032] Acanthamoeba Keratitis (AK) Market The dynamics of the Acanthamoeba Keratitis (AK) market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as PHMB 0.08%, Propamidine, and others during the forecasted period 2019-2032. Learn more by requesting for sample @ Acanthamoeba Keratitis (AK) Market Landscape Acanthamoeba Keratitis (AK) Pipeline Therapies: ● ● ● ● PHMB 0.08% Propamidine Chlorhexidine Moxifloxacin Ophthalmic Acanthamoeba Keratitis (AK) Pipeline Key Companies: ● ● SIFI SpA Aravind Eye Care System Click here to read more about Acanthamoeba Keratitis (AK) Market Outlook 2032 Related Reports: Acanthamoeba Keratitis (AK) Pipeline "Acanthamoeba Keratitis (AK) Pipeline Insight, 2022" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Acanthamoeba Keratitis (AK) market. A detailed picture of the Acanthamoeba Keratitis (AK) pipeline landscape is provided, which includes the disease overview and Acanthamoeba Keratitis (AK) treatment guidelines. Acanthamoeba Keratitis (AK) Epidemiology DelveInsight's 'Acanthamoeba Keratitis (AK) Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Acanthamoeba Keratitis (AK) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Diagnostic Imaging Equipment Market Diagnostic Imaging Equipment Market By Product (X-Ray Imaging Systems, Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI) Systems, Nuclear Imaging

3. Systems, Mammography Systems, And Others), By Application (Cardiology, Oncology, Gastroenterology, Gynecology, And Other Applications), By End-User (Hospitals, Diagnostic Imaging Centres, And Others), by geography is expected to grow at a steady CAGR forecast till 2026 owing to rising technological advancement and increasing prevalence of chronic diseases. Invasive Candidiasis Market "DelveInsight’s ‘Invasive Candidiasis Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Invasive Candidiasis and the historical and forecasted Invasive Candidiasis market trends, globally, which comprises of North America, Europe, APAC, and RoW. Sialidosis Market DelveInsight's "Sialidosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Sialidosis, historical and forecasted epidemiology as well as the Sialidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Filgrastim Biosimilar Insight DelveInsight’s, “Filgrastim Biosimilar Insight, 2022,” report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in the Filgrastim Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Pain Management Devices Market Pain Management Devices Market By Type Of Devices (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices And Cryoablation Devices], And Others), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), By Geography is expected to grow at a steady CAGR Forecast till 2027 Latest Reports by DelveInsight Basal Cell Carcinoma Market | Birch Allergy Market | Bile Duct Neoplasm Market | Gingivitis Market | Lupus Nephritis Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Congestive Heart Failure Market | Gingivitis Market | Lupus Nephritis Market | Erythromelalgia Market | AL Amyloidosis Market | Primordial Dwarfism Market | Breast Pumps Market | Hyperuricemia Market | Helicobacter Pylori (H. pylori) Infection Market | AIDS Dementia- Market | Follicular Lymphoma Market | Chronic Pulmonary Hypertension Market | Adrenal Crisis Market | Retinoblastoma Market | Non-Cystic Fibrosis Bronchiectasis Market | Microsatellite Stable Colorectal Cancer Market | Chondrosarcoma Market | Sialidosis Market To know more about our Competitive Services, Click here: Pharma Competitive Intelligence

4. https://www.delveinsight.com/consulting/competitive-intelligence-serviceshttps://www.delveinsight.com/consulting/competitive-intelligence-services